Corporate Board Profile
| Filing Date | Source Excerpt |
|---|---|
| 2024-09-27 | June Almenoff, MD, PhD 59,500 |
| 2024-04-26 | Dr. Almenoff is currently the Chief Medical Officer at RedHill Biopharma Inc. (NASDAQ: RDHL), a specialty biopharmaceutical company. |
| 2023-10-27 | ...June Almenoff, MD, Phd...* Less than 1%... |
| 2023-04-28 | Dr. Almenoff is currently the Chief Medical Officer at RedHill Biopharma Inc. (NASDAQ: RDHL), a specialty biopharmaceutical company. |
| 2022-04-28 | Dr. Almenoff received her B.A. cum laude from Smith College and graduated with AOA honors from the M.D.-Ph.D. program at the Icahn (Mt. Sinai) School of Medicine. |
| 2021-04-30 | Dr. Almenoff is an accomplished biopharma executive with over 20 years of senior leadership experience. |
Data sourced from SEC filings. Last updated: 2025-04-26